Randomized, Controlled Trial of Extended-Release Niacin (NiaspanĀ®) to Augment Subacute Ischemic Stroke Recovery


Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to determine the safety, tolerability, and to explore the possible benefit of extended-release niacin (NiaspanĀ®) in attempting to improve the recovery of patients after ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 September 2012.

1 Apr 2009 21 Nov 2008 1 Aug 2012 1 Aug 2012 1 Sep 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment